Merck abandons HIV vaccine trials
37552
The drug giant Merck suspends trials on an HIV vaccine that was regarded as one of the most promising.
63495
Scientists are no nearer finding a vaccine against HIV after more than 20 years of research, a top expert says.
333725
Merck &amp; Co. (MRK.N: Quote, Profile, Research) said on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
17202
Baxter International Inc. on Thursday  said it halted a late-stage European trial of a flu vaccine  because of higher-than-expected rates of fever and other  symptoms.
192773
Merck announced on Sept. 29 a voluntary worldwide withdrawal of Vioxx (rofecoxib), a so-called COX-2 selective nonsteroidal anti-inflammatory drug, or NSAID.
717890
Pfizer Inc. said Saturday it has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it.
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
674284
In a setback for flu vaccine development, Deerfield-based Baxter International Inc. said today it has suspended enrollment in a late-stage European trial for a cell-based flu vaccine.
238647
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises the risk of heart attack and stroke, the manufacturer, Merck & Co. , said on Thursday.
621442
Bowing to pressure from parents and medical groups, Merck &amp; Co. is suspending its lobbying campaign to persuade legislatures to mandate that adolescent girls get the company's vaccine against cervical cancer as a requirement to attend school.
252707
Sanofi-Aventis has withdrawn its  marketing application for its Multaq heart arrhythmia treatment  in the European Union, the world's third-largest drugmaker said  on Thursday.
19693
An arthritis drug should have been taken off the market years before it was finally withdrawn, say researchers. Manufacturer Merck withdrew Vioxx in September after evidence linking it to heart problems.
247288
Merck &amp; Co. withdrew its Vioxx painkiller, which generated $2.5 billion in sales last year, because of a link to heart attacks and strokes.
380230
MedImmune Inc. said Monday it has ended advanced human testing of its drug Vitaxin to treat rheumatoid arthritis and psoriasis because it failed to show clinical benefits in preliminary results. -The Washington Post
756760
Decode Genetics Inc. said on Thursday  it was halting its late-stage clinical trial program for an  experimental oral heart attack drug after a formulation problem  with the tablets cropped up.
137864
TRENTON, N.J., Sept. 21 -- A promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study.
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.